Labcorp Launches New Genetic Testing Platform 'Marker', Shares Hit 52-Week High
LH sits 23% above its 52-week low of $244.52.
Summary
Labcorp launched 'Marker,' a new genetic testing platform that will be available through Labcorp OnDemand starting August 3, 2026. This platform analyzes 163 genes to assess genetic risk for cardiovascular diseases and metabolic conditions, expanding consumer access to personalized hereditary health panels. The news coincides with Labcorp shares reaching a 52-week high. This launch represents a new revenue stream and strengthens Labcorp's position in the growing genetic testing market, following other recent diagnostic product introductions.
At the time of this announcement, LH was trading at $301.60 on NYSE in the Life Sciences sector, with a market capitalization of approximately $24.7B. The 52-week trading range was $244.52 to $301.79. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.